|
mRNA_ID
|
Gene Name
|
drug_ID
|
drug_Name
|
Disease
|
RNA_exp_pattern
|
Evidence
|
Details
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Prostate Cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Bladder Cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Nasopharyngeal carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Osteosarcoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Hepatoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Prostate Cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Hepatocellular carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Breast cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Pancreatic Cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Hepatocellular carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Lung cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Cervical cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Breast cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Hepatocellular carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Multiple Myeloma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Oral squamous cell cancer (OSCC)
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Neuroblastoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Laryngeal squamous cell cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Bladder Cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Hepatocellular carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Cervical cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Hepatocellular carcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Bladder Cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Colorectal cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Osteosarcoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Myeloma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Colon cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Breast cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Lung Adenocarcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Gastric cancer
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
P21
|
NA
|
NA
|
Pancreatic ductal adenocarcinoma
|
down-regulated
|
predicted
|
more...
|
|
ENST00000244741
|
CDKN1A
|
DB00313
|
Valproic acid
|
endometriosis
|
down-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A
|
DB17048
|
Plumbagin
|
glioma
|
down-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A
|
DB01126
|
Dutasteride
|
bladder cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A
|
DB16865
|
Rosmarinic acid
|
pancreatic ductal adenocarcinoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A
|
DB01043
|
Memantine
|
lung cancer
|
down-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A
|
DB00130
|
L-Glutamine
|
myocardial ischemia-reperfusion injury
|
down-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A
|
NA
|
Osthole
|
diabetic nephropathy
|
down-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A
|
NA
|
HTI-286
|
prostate cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
DB12362
|
DAPT
|
endometrial cancer
|
Up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
DB01055 (APRD00647)
|
Mimosine
|
breast cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
DB12207
|
Verdinexor (KPT-35)
|
melanoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
DB01275
|
Hydralazine
|
prostate cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
DB14981
|
Fytic acid(Inositol hexaphosphate)
|
colon cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
DB03756 (EXPT01798, DB11070)
|
Doconexent(DHA)
|
colon cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
NA
|
Thymoquinone
|
colon cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
NA
|
Eeyarestatin 1 (EER-1)
|
lymphoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
NA
|
OEL (1-oxoeudesm-11(13)eno-12,8a-lactone)
|
glioblastoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
DB00188 (APRD00828, DB07475)
|
Bortezomib
|
hepatocellular carcinoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
DB00877 (APRD00178, DB02439)
|
Sirolimus(Rapamycin)
|
hepatocellular carcinoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
NA
|
6-Shogaol
|
prostate cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
DB14060
|
NS-398
|
hepatocellular carcinoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
DB04743
|
Nimesulide
|
hepatocellular carcinoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
DB12681
|
Salirasib
|
hepatocellular carcinoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
NA
|
Ochratoxin A
|
hepatocellular carcinoma
|
down-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
DB07352
|
Apigenin
|
lung cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
DB04996
|
Satraplatin
|
colon cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
P21 (CDKN1A)
|
NA
|
SL4
|
breast cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
P21 ( CDKN1A)
|
DB06603
|
Panobinostat
|
esophageal cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
P21 ( CDKN1A)
|
DB00136 (NUTR00003, APRD00246, DB05314)
|
Calcitriol (1-alpha-25-Dihydroxyvitamin D3)
|
head and neck squamous cell carcinoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
NA
|
Tenovin-D3
|
cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
P21 ( CDKN1A)
|
DB00197 (APRD00488)
|
Troglitazone
|
pancreatic cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
P21 ( CDKN1A)
|
NA
|
Ceramide
|
hepatocellular carcinoma
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
CDKN1A (P21)
|
DB03568 (EXPT00774)
|
Butyric Acid
|
lung cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
P21 ( CDKN1A)
|
DB00755 (NUTR00051, APRD00362)
|
All-trans retinoic acid (ATRA)
|
cervical cancer
|
up-regulated
|
validated
|
more...
|
|
ENST00000244741
|
P21 ( CDKN1A)
|
NA
|
XI011
|
breast cancer
|
up-regulated
|
validated
|
more...
|